Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.comppsych.2012.06.006 http://scihub22266oqcxt.onion/10.1016/j.comppsych.2012.06.006 C5502713!5502713 !22901834     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\22901834 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Compr+Psychiatry 2013 ; 54 (1 ): 1-6 Nephropedia Template TP {{tp|p=22901834 |t=2013. The diagnosis of depression: current and emerging methods |pdf=|usr=}}{{22901834 }} gab.com Text The diagnosis of depression: current and emerging methods JO: Compr Psychiatry http://www.kidney.de/pget.php?&tw=1&pmid=22901834 #FOAvip Depression is one of the leading causes of disability in adolescents and adults, particularly starting from age 15 years and older. Diagnosis of depression has traditionally been made based on clinical criteria, including patient current symptoms and history. This process is widely used but relies on subjective interpretation. To standardize both the data obtained and data interpretation, various interview-based instruments and noninterview methods exist for screening and testing for depression in various clinical settings. This article evaluates the technical basis for and clinical performance of these various instruments and methods to diagnosis depression in clinical settings. Traditional tools include physician-administered or patient self-administered interview tools that have reasonable clinical accuracy depending on the threshold score and may lead to a full diagnostic evaluation for high-risk patients. In addition, older laboratory methods such as the dexamethasone test have contributed to the diagnosis of depression over a long period. Newer diagnostic methods such as genomics, proteomics, and metabolomics are technically sophisticated and objective and are beginning to emerge in psychiatry. Although promising, further evaluation of these methods is needed to fully demonstrate their clinical value and accuracy. Twit Text FOAVip The diagnosis of depression: current and emerging methods ????Compr Psychiatry http://www.kidney.de/pget.php?&tw=1&pmid=22901834 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=22901834 #FOAvip English Wikipedia <ref>{{Cite pmid|22901834 }}</ref> The diagnosis of depression: current and emerging methods #MMPMID22901834 Smith KM ; Renshaw PF ; Bilello J Compr Psychiatry 2013[Jan]; 54 (1 ): 1-6 PMID22901834 show ga Depression is one of the leading causes of disability in adolescents and adults, particularly starting from age 15 years and older. Diagnosis of depression has traditionally been made based on clinical criteria, including patient current symptoms and history. This process is widely used but relies on subjective interpretation. To standardize both the data obtained and data interpretation, various interview-based instruments and noninterview methods exist for screening and testing for depression in various clinical settings. This article evaluates the technical basis for and clinical performance of these various instruments and methods to diagnosis depression in clinical settings. Traditional tools include physician-administered or patient self-administered interview tools that have reasonable clinical accuracy depending on the threshold score and may lead to a full diagnostic evaluation for high-risk patients. In addition, older laboratory methods such as the dexamethasone test have contributed to the diagnosis of depression over a long period. Newer diagnostic methods such as genomics, proteomics, and metabolomics are technically sophisticated and objective and are beginning to emerge in psychiatry. Although promising, further evaluation of these methods is needed to fully demonstrate their clinical value and accuracy. |Biomarkers [MESH] |Depressive Disorder, Major/*diagnosis [MESH] |Dexamethasone [MESH] |Gene Expression Profiling [MESH] |Genomics [MESH] |Glucocorticoids [MESH] |Humans [MESH] |Interview, Psychological [MESH] |Metabolomics [MESH] |Proteomics [MESH] |Sensitivity and Specificity [MESH]The diagnosis of depression: current and emerging methods (epmc).pdf DeepDyve Pubget Overpricing